PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
24-Jun-2025 Phastar appoints Industry Veteran Billy Amzal as Head of Strategic Consulting Phastar
24-Jun-2025 Black Book Research Announces Top-Rated Vendors for Ancillary Revenue Cycle Management Solutions for 2025, Highlighting Excellence Across Niche Healthcare Sectors ACCESS Newswire
24-Jun-2025 Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program Priothera
24-Jun-2025 Qlucore Receives Approval for 0.5M EUR Installment from the EU Qlucore
24-Jun-2025 Verisma Recognized as Top Release of Information Solution in Black Book Survey, Demonstrating Superior Client Satisfaction Across New ROI Key Performance Indicators ACCESS Newswire
24-Jun-2025 Documo Appoints Veteran Healthcare Executive BJ Boyle to Board of Directors ACCESS Newswire
24-Jun-2025 Mim8 (denecimig) prophylaxis was well-tolerated in FRONTIER5 phase 3 switch trial in people with haemophilia A Novo Nordisk
24-Jun-2025 Xcell Biosciences Announces Joint Research Collaboration with Thermo Fisher Scientific to Advance the Next Generation of Cell Therapies Xcell Biosciences
24-Jun-2025 Cercare Medical Selected for Nationwide Hospital Rollout in Norway ACCESS Newswire
24-Jun-2025 Artificial Intelligence Helps to Detect Dangerous Colon Polyps KL Krems
24-Jun-2025 Evaluate Releases Updated Pharmaceutical Market Forecasts in Annual World Preview Report Evaluate
24-Jun-2025 Union Pacific Sued Over Train Sparks that Allegedly Ignited Rowena Fire ACCESS Newswire
24-Jun-2025 CanSinoBIO Launches Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health CanSino Biologics Inc
24-Jun-2025 19 AI-Powered RCM Solutions to Solve Healthcare Providers' Financial Woes: Top Vendors Named in Black Book's Survey ACCESS Newswire
24-Jun-2025 Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Immunic AG
24-Jun-2025 Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for the treatment of congenital adrenal hyperplasia Lundbeck
24-Jun-2025 CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment Discussing Glioblastoma Multiforme (GBM) and Lead Product Candidate TPI 287 ACCESS Newswire
24-Jun-2025 Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy Breye Therapeutics
24-Jun-2025 Polaroid Therapeutics Teams Up With Ingenix.Ai To Supercharge Clinical Trials With Multimodal Agentic AI To Accelerate Advanced Patient-Centred Therapies Polaroid Therapeutics
24-Jun-2025 Healthcare Industry Expert Greg Helman Joins SpendMend ACCESS Newswire